The Italian impact fund, which focuses on high-growth companies in the health and wellbeing sectors, is aiming to double its fundraising target next year.
The investor is seeking to support emerging markets infrastructure development in the areas of renewable energy, clean mobility, health, water, and sanitation.
Jinko offers personalised supportive care to people affected by cancer. The company aims to use the funds to grow its partnerships, boost its visibility among patients and healthcare professionals, and enhance its digital application.
Impact investors are making allocations to Redcliffe Labs, the Indian diagnostics service provider. The country’s diagnostics market is estimated to be worth about $15bn this year, with expected growth of 15% annually until 2030.
The aim is to increase healthcare capacity in the Netherlands. The first investment is in Momo Medical, which has developed an app to support more efficient working in nursing homes.
Breast cancer deaths disproportionately affect women in low- and middle-income countries. However, healthtech innovations are increasingly making life-saving screening more accessible.
Keynote speaker Sarah de Lagarde will discuss the impact of healthtech at this year’s Impact Investor Conference. But before that, Sarah, a double amputee, will be attempting to climb Kilimanjaro and raise funds for STAND.
The Swedish impact investor’s inaugural venture fund was backed by European institutional investors and will back companies developing solutions to address future health and environmental challenges.